Afatinib N-oxide is an active pharmaceutical ingredient metabolite, specifically an oxidized derivative of afatinib. It is a quinazoline-based compound with an N-oxide functional group, characterized by aromatic rings, ether linkages, and halogen substituents.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2413212-11-8
Afatinib impurity 12
pharmaceutical intermediate
Afatinib Impurity I
pharmaceutical intermediate
N4-(3-chloro-4-fluorophenyl)-7-(((3S)-tetrahydro-3-furanyl)oxy)-4,6-quinazolinediamine
pharmaceutical raw material
1-hydroxymidazolam
pharmaceutical raw material
2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)acetic acid
pharmaceutical raw material
EXP-3174
pharmaceutical raw material
Isavuconazole
pharmaceutical raw material
Isoconazole nitrate
pharmaceutical raw material
(E)-4-[[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]amino]-N,N-dimethyl-4-oxobut-2-en-1-amine oxide
IABSYXLQTGEUIV-CWDCEQMOSA-N
C[N+](C)(C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)[O-]